CELLZOME AND SANTHERA´S BUSINESS UNIT, GRAFFINITY, AWARDED € 2.2 MILLION GRANT FROM GERMAN GOVERNMENT

Cellzome AG and Graffinity announced today that they will receive €2.2 million --€1.1 million each -- from the German Ministry of Research and Education for the discovery of novel treatments for disorders of the immune system. Cellzome and Graffinity will exploit their complementary technologies for the discovery of novel, selective small molecule leads, initially directed against several kinases in signalling pathways of the immune system. Over the course of the next two years, Graffinity will screen up to nine Cellzome targets using its unique fragment-based screening platform.

Biotech Intelligence (http://www.biotech-intelligence.com/html/html/456c699b9220451556aa6b252679a0af.html)